Effects of Neoadjuvant Immunotherapy on Patients With Lung Cancer: a Prospective, Observational Study
Status: Recruiting
Location: See location...
Intervention Type: Radiation, Procedure, Drug
Study Type: Observational
SUMMARY
The goal of this observational study is to learn about the long-term effects of neoadjuvant immunotherapy in patients with lung cancer. The main questions it aims to answer are: * Does pneumonectomy bring more benefits for pateints than lobectomy? * Does surgery bring more benefits for patients than non-surgery modalities (such as radiotherapy) after neoadjuvnat immunotherapy? Participants will receive neoadjuvant treatment and the study will analyze the data.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 79
View:
• Aged between 18 and 79 years;
• Received at least two cycles of neoadjuvant immunotherapy;
• ECOG performance status score of 0;
• Complete clinical information including imaging data available.
Locations
Other Locations
China
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITING
Beijing
Contact Information
Primary
Shugeng Gao, MD
gaoshugeng@cicams.ac.cn
8610-87788177
Time Frame
Start Date: 2025-04-20
Estimated Completion Date: 2030-04-14
Participants
Target number of participants: 500
Treatments
Surgery
Patients will undergo surgery after neoadjuvant immunotherapy.
Non-surgery
Patients will receive non-surgical treatment after neoadjuvant treatment.
Related Therapeutic Areas
Sponsors
Leads: Cancer Institute and Hospital, Chinese Academy of Medical Sciences